Why the study?
Panax ginseng exhibits potent pro-angiogenic properties, motivating an examination of its pro-angiogenic activities and underlying mechanisms for treating ischemic diseases.
Does Panax ginseng promote angiogenesis in ischemic diseases?
Does Panax ginseng promote angiogenesis in ischemic diseases?
Panax ginseng and its derivatives demonstrate potent pro-angiogenic properties, suggesting potential therapeutic value for ischemic diseases.
Answers are grounded in this paper and cite their sources.
May support adjunctive ginseng use in ischemic disease; leaves open efficacy confirmation in prospective trials.
Ischemic diseases, including coronary heart disease and peripheral arterial obstructive disease, pose significant health threats worldwide. Angiogenic therapy has emerged as a comprehensive approach to combat these diseases. In recent years, traditional Chinese medicine has attracted increased attention due to its demonstrable therapeutic effects on ischemic diseases. Panax ginseng, a perennial herb from the Panax genus of the Araliaceae family, is widely employed in the clinical treatment of ischemic conditions. Previous research reveals that Panax ginseng exhibits potent pro-angiogenic properties. In this review, we present a timely examination of the pro-angiogenic activities and underlying mechanisms of Panax ginseng, its extracts, and its constituent compounds. Overall, this review offers a comprehensive understanding of the relationship between Panax ginseng and pro-angiogenesis, providing novel insights for clinical practice.
No takes yet. Share an insight, caveat, or question.
Song et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: